NCT06528288 Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery
| NCT ID | NCT06528288 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Fusion of Spine, Lumbar Region |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2024-09-13 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2024-09-13 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if the method for injecting local anesthesia affects patients' pain and opioid usage after surgery. The investigators will compare subcutaneous anesthesia, injections of anesthesia under the skin, to a method called erector spinae plane block (ESPB). An ESPB injection involves placing local anesthesia along the muscles and bones in the back, using a special type of x-ray called fluoroscopy for guidance. The Investigators will use patient reported outcomes (PROs) and track subjects' opioid usage to find out if there is a difference between ESPB and subcutaneous anesthesia. The investigators hypothesize that patients who get ESPB injections will use less opioids and report less pain after lumbar fusion surgery compared to patients who receive subcutaneous anesthesia injections.
Eligibility Criteria
Inclusion Criteria: * The individual has signed and dated a study specific informed consent form approved by the Institutional Review Board at UMMHC. * The individual is at least 18 years of age. * The individual is skeletally mature (over the age of 18). * The patient is scheduled for a one or two level lumbar spinal fusion. Exclusion Criteria: * Patients unable to consent for themselves. * Pregnant women. * Non-English speaking subjects. * Prisoners. * Spinal fusion procedures for a diagnosis of fracture, tumor, and/or infection. * Patients who have used greater than 150 morphine milligram equivalents of opioids in the month prior to their operation. * Patients with a body mass index (BMI) of 40 or greater.
Contact & Investigator
Michael Stauff, MD
PRINCIPAL INVESTIGATOR
UMass Chan Medical School
Frequently Asked Questions
Who can join the NCT06528288 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fusion of Spine, Lumbar Region. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06528288 currently recruiting?
Yes, NCT06528288 is actively recruiting participants. Contact the research team at Michael.Stauff@umassmed.edu for enrollment information.
Where is the NCT06528288 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT06528288 clinical trial?
NCT06528288 is sponsored by University of Massachusetts, Worcester. The principal investigator is Michael Stauff, MD at UMass Chan Medical School. The trial plans to enroll 66 participants.